GLP-1/glucagon co-agonism lowers liver fat more than GLP-1 but not glucagon mono-agonism in obese mice

被引：0
|
作者：
Winther-Sorensen, M. [1 ,2 ]
Rasmussen, C. [1 ]
Trammell, S. A. J. [3 ]
Serizawa, R. R. [4 ]
Vyberg, M. [4 ]
Richter, E. A. [5 ]
Grevengoed, T. [3 ]
Gluud, L. L. [6 ]
Kuhre, R. E. [7 ,8 ]
Albrechtsen, N. J. Wewer [1 ,2 ]
机构：
[1] Bispebjerg Hosp, Dept Clin Biochem, Copenhagen NV, Denmark
[2] Univ Copenhagen, NNF Ctr Prot Res, Copenhagen N, Denmark
[3] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark
[4] Copenhagen Univ Hosp Hvidovre, Dept Pathol, Hvidovre, Denmark
[5] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark
[6] Copenhagen Univ Hosp Hvidovre, Gastro Unit, Hvidovre, Denmark
[7] Novo Nordisk, Dept Obes, Malov, Denmark
[8] Novo Nordisk, NASH Pharmacol, Malov, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LBA 57
引用
收藏
页码：S536 / S536
页数：1
相关论文
共 50 条
  • [21] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [22] GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISM IMPROVES BIOCHEMICAL AND HISTOPATHOLOGICAL INDICES OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN MICE
    Trevaskis, James L.
    Griffin, Peter
    Wittmer, Carrie
    Neuschwander-Tetri, Brent A.
    Brunt, Elizabeth M.
    Bilakovics, James M.
    Crogan-Grundy, Candace
    Lowe, Carolyn
    Parkes, David
    Roth, Jonathan D.
    HEPATOLOGY, 2010, 52 (04) : 1061A - 1061A
  • [23] Discovery of novel cyclic peptides which exhibit glucagon-like peptide-1 (GLP-1) receptor agonism
    Limberakis, Chris
    Aspnes, Gary
    Derksen, David
    Edmonds, David
    Eng, Heather
    Fairlie, David
    Goetz, Gilles
    Gopalsamy, Ariamala
    Griffith, David
    Hill, Timothy
    Huy Hoang
    Kalgutkar, Amit
    Kok, W.
    Liras, Spiros
    Mascitti, Vincent
    Mathiowetz, Alan
    Mitchell, Justin
    Piotrowski, David
    Price, David
    Rotter, Charles
    Ruggeri, Roger
    Song, Kun
    Stanton, Robert
    Suen, Jacky
    Withka, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [24] Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice
    Vanslette, Amanda Marie
    Toft, Pernille Baumann
    Lund, Mari Lilith
    Moritz, Thomas
    Arora, Tulika
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 960
  • [25] Agonism of the glucagon-like peptide 1 (GLP-1) receptor attenuates sepsis-induced acute lung injury
    Baer, Brandon
    Putz, Nathan D.
    Gibson, Dustin
    Ware, Lorraine B.
    Toki, Shinji
    Peebles, Ray S.
    Cahill, Katherine N.
    Bastarache, Julie A.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [26] Identification of glucagon like peptide-1 (GLP-1) in mice stomach
    Otsuka, Manami
    Huang, Jin
    Tanaka, Toru
    Sakata, Ichiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 704
  • [27] Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo
    Wu, Ye-Lin
    Huang, Jing
    Xu, Jin
    Liu, Jian
    Feng, Zhen
    Wang, Yang
    Lai, Yuping
    Wu, Zi-Rong
    REGULATORY PEPTIDES, 2010, 164 (2-3) : 83 - 89
  • [28] Effect of metformin on glucagon-peptide 1 (GLP-1) secretion in obese patients
    Mannucci, E
    Ognibene, A
    Cremasco, F
    Bardini, G
    Pierazzuoli, E
    Mencucci, A
    Rotella, CM
    DIABETES, 1999, 48 : A118 - A118
  • [29] Combining GLP-1 and glucagon for the treatment of obesity and diabetes
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 481 - 482
  • [30] Glucagon-like peptide 1 (GLP-1) and eating
    Gutzwiller, JP
    Degen, L
    Heuss, L
    Beglinger, C
    PHYSIOLOGY & BEHAVIOR, 2004, 82 (01) : 17 - 19
12345